Yang Chun-Pai, Hsieh Ching-Liang, Wang Nai-Hwei, Li Tsai-Chung, Hwang Kai-Lin, Yu Shin-Chieh, Chang Ming-Hong
Department of Neurology, Kuang Tien General Hospital, Taiwan.
Clin J Pain. 2009 May;25(4):327-33. doi: 10.1097/AJP.0b013e318190511c.
To investigate the efficacy of acupuncture compared with steroid treatment in patients with mild-to-moderate carpal tunnel syndrome (CTS) as measured by objective changes in nerve conduction studies (NCS) and subjective symptoms assessment in a randomized, controlled study.
A total of 77 consecutive and prospective CTS patients confirmed by NCS were enrolled in the study. Those who had fixed sensory complaint over the median nerve and thenar muscle atrophy were excluded. The CTS patients were randomly divided into 2 treatment arms: (1) 2 weeks of prednisolone 20 mg daily followed by 2 weeks of prednisolone 10 mg daily (n = 39), and (2) acupuncture administered in 8 sessions over 4 weeks (n = 38). A validated standard questionnaire as a subjective measurement was used to rate the 5 major symptoms (pain, numbness, paresthesia, weakness/clumsiness, and nocturnal awakening) on a scale from 0 (no symptoms) to 10 (very severe). The total score in each of the 5 categories was termed the global symptom score (GSS). Patients completed standard questionnaires at baseline and 2 and 4 weeks later. The changes in GSS were analyzed to evaluate the statistical significance. NCS were performed at baseline and repeated at the end of the study to assess improvement. All main analyses used intent-to-treat.
A total of 77 patients who fulfilled the criteria for mild-to-moderate CTS were recruited in the study. There were 38 in the acupuncture group and 39 in the steroid group. The evaluation of GSS showed that there was a high percentage of improvement in both groups at weeks 2 and 4 (P < 0.01), though statistical significance was not demonstrated between the 2 groups (P = 0.15). Of the 5 main symptoms scores (pain, numbness, paresthesia, weakness/clumsiness, nocturnal awakening), only 1, nocturnal awakening, showed a significant decrease in acupuncture compared with the steroid group at week 4 (P = 0.03). Patients with acupuncture treatment had a significant decrease in distal motor latency compared with the steroid group at week 4 (P = 0.012). Acupuncture was well tolerated with minimal adverse effects.
Short-term acupuncture treatment is as effective as short-term low-dose prednisolone for mild-to-moderate CTS. For those who do have an intolerance or contraindication for oral steroid or for those who do not opt for early surgery, acupuncture treatment provides an alternative choice.
在一项随机对照研究中,通过神经传导研究(NCS)的客观变化和主观症状评估,调查针刺疗法与类固醇治疗相比对轻至中度腕管综合征(CTS)患者的疗效。
共有77例经NCS确诊的连续性前瞻性CTS患者纳入本研究。排除那些正中神经有固定感觉异常和大鱼际肌萎缩的患者。CTS患者被随机分为2个治疗组:(1)每天服用20 mg泼尼松龙2周,随后每天服用10 mg泼尼松龙2周(n = 39),以及(2)在4周内进行8次针刺治疗(n = 38)。使用经过验证的标准问卷作为主观测量工具,对5种主要症状(疼痛、麻木、感觉异常、无力/笨拙和夜间觉醒)进行评分,评分范围为0(无症状)至10(非常严重)。5个类别中每个类别的总分称为总体症状评分(GSS)。患者在基线时以及2周和4周后完成标准问卷。分析GSS的变化以评估统计学意义。在基线时进行NCS,并在研究结束时重复进行以评估改善情况。所有主要分析均采用意向性分析。
共有77例符合轻至中度CTS标准的患者纳入本研究。针刺组38例,类固醇组39例°GSS评估显示,两组在第2周和第4周时改善率均较高(P < 0.01),但两组之间未显示出统计学意义(P = 0.15)。在5种主要症状评分(疼痛、麻木、感觉异常、无力/笨拙、夜间觉醒)中,只有夜间觉醒在第4周时与类固醇组相比,针刺组有显著下降(P = 0.03)。在第4周时,与类固醇组相比,接受针刺治疗的患者远端运动潜伏期显著缩短(P = 0.012)。针刺疗法耐受性良好,不良反应最小。
短期针刺治疗对轻至中度CTS的疗效与短期低剂量泼尼松龙相当。对于那些对口服类固醇不耐受或有禁忌证的患者,或者那些不选择早期手术的患者,针刺治疗提供了一种替代选择。